Announcements Trials

Browse Landscape

Phase

Phase 1 35 Phase 2 28 Phase 1/2 11 Phase NA 7 Phase 3 4 Phase EARLY_PHASE1 2 Phase 2/3 1

Status

Completed 2 Withdrawn 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 13 Neoplasms 10 Carcinoma, Non-Small-Cell Lung 10 Lung Neoplasms 9 Recurrence 6 Prostatic Neoplasms 6 Neoplasm Metastasis 6 Head and Neck Neoplasms 6 Carcinoma, Hepatocellular 6 Stomach Neoplasms 5 Pancreatic Neoplasms 5 Colorectal Neoplasms 5 Carcinoma, Squamous Cell 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Multiple Myeloma 4 Melanoma 4 Liver Neoplasms 4 Ovarian Neoplasms 3 Myelodysplastic Syndromes 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Large B-Cell, Diffuse 3 Hematologic Neoplasms 3 Fatigue 3 Esophageal Neoplasms 3 Endometrial Neoplasms 3 Depression 3 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Rectal Neoplasms 2

Interventions

vocimagene amiretrorepvec 1 Temozolomide 1 Lomustine 1 Flucytosine 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Terminated × Astrocytoma × Clear all

NCT02414165 2020-02-07

Toca5

Tocagen Inc.

Phase 2/3 Terminated

Astrocytoma, Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡